Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Sensex Today | Stock Market Live: Sensex jumps over 500 points, Nifty tops 23,800; banks lead, pharma drags - Moneycontrol.com
Sensex Today | Stock Market Live: Sensex jumps over 500 points, Nifty tops 23,800; banks lead, pharma dragsMoneycontrol.com

Mint Explainer: Are Sebi's third-party mutual fund payments a risk or convenience?
Sebi has recommended third-party transactions for mutual fund investments in certain scenarios in a consultation paper issued on Wednesday.

Q4 Results LIVE Updates: Max Health shares decline 7%, Honasa Consumer up 7%; Hindalco report today
Q4 Results Live Update: Another busy earnings week ends with three Nifty names - Sun Pharma, Eicher Motors and Hindalco reporting their results today, along with broader market names like Torrent Pharma, Fortis Healthcare, DAM Capital, Colgate-Palmolive, IRCON International, Jubilant Pharmova, Minda Corp, and many others. LG, LIC, GAIL, ITC, will also be reacting to their results reported on Thursday.
Nandish Shah of HDFC Sec suggests Bear Spread on Nifty; key levels here
Nandish Shah of HDFC Securities has shared a Bear Spread strategy on Nifty, and a Bull Spread strategy on Aurobindo Pharma.
Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments Bank
Benchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to continue its consolidation between 23,200 and 23,900. Several companies, including ITC, LIC, Sun Pharma, Maruti Suzuki, and Fino Payments Bank, are in focus due to Q4 results and other developments.
Over 15 MF schemes cut exposure to these 10 stocks in April ’26. Do you own any?
Over 15 mutual fund schemes trimmed stakes in 10 major stocks in April 2026, signalling growing caution as market volatility and geopolitical risks rise.
Aurobindo Pharma Ltd up for third consecutive session
Aurobindo Pharma Ltd is quoting at Rs 1541.4, up 1.57% on the day as on 12:49 IST on the NSE. The stock is up 29.73% in last one year as compared to a 3.98% slide in NIFTY and a 15.38% slide in the Nifty Pharma index.

Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?
The Nifty Pharma index has surged nearly 11% over the past month, significantly outperforming the Nifty 50, which declined 3.6% during the same period. On a year-to-date (YTD) basis, the Nifty Pharma index has gained 9.4%, while the benchmark Nifty 50 has fallen by an equal margin.

Is buy-on-dips strategy truly working for mutual fund investors? Here's what past 2-year data reveal - Mint
Is buy-on-dips strategy truly working for mutual fund investors? Here's what past 2-year data revealMint
Is your mutual fund SIP secretly crushing the Indian rupee? Jefferies explains the bitter side of the story
India's strong mutual fund SIP culture is helping foreign investors exit the equity market. This is putting pressure on the Indian Rupee. Jefferies reports that capital flows are low, not the current account deficit. Foreign investors have sold equities worth billions. Domestic savings are now funding these outflows. The Rupee is undervalued, but a rebound is possible.
Is your mutual fund SIP secretly crushing the Indian rupee? Jefferies explains the bitter side of the story - The Economic Times
Is your mutual fund SIP secretly crushing the Indian rupee? Jefferies explains the bitter side of the storyThe Economic Times
Edelweiss MF unveils second SIF offering; Parle confusion lifts stock
Edelweiss Mutual Fund launched its second specialised investment fund offering, while shares of Parle Industries surged after traders mistook it for the maker of Melody toffees